tirzepatide + b3 / Niacinamide Injection Tirzepatide B3 Injections

Who Should Consider Alternative Formulations or Dosing Strategies Patients with a history of severe nausea, vomiting disorders (like cyclic vomiting syndrome), concurrent gastrointestinal conditions (GERD, gastroparesis), or those taking medications that increase nausea risk may benefit from slower escalation protocols or alternative GLP-1 agents

Vomiting rates were 6-10% for tirzepatide and 8% for semaglutide

A RECENT study has revealed that a significant proportion of adults prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight management discontinue treatment within a year, with discontinuation rates notably higher among those without Type 2 diabetes

Combining tirzepatide with other medications without medical supervision can increase side effects like hypoglycemia, dehydration, or gastrointestinal discomfort

In a recent systematic review and meta-analysis of 39 observational studies, use of folic acid-containing supplements preconceptionally or during pregnancy was associated with a 42% lower risk of CL/P (95% CI, 0.49-0.70) (64)